Drug Chatter -- Tracking biopharma stock chatter

Profile for Coherus BioSciences, Inc. (CHRS)

« Back to company index

CHRS Chatter Timeline

Stock Ticker for CHRS

Most Active Tweeters for CHRS

UserTweets
@SleekMoneycom 8
@TheMarketsDaily 4
@TickerReport 4
@bnbdailynews 3
@dailymailtimes 3

Recent Tweets for CHRS

TheMarketsDaily @TheMarketsDaily
Coherus BioSciences, Inc. $CHRS Stock Price Up 4.9% https://t.co/y4PTkxEzZi
September 25th 2017, 9:09pm
SleekMoneycom @SleekMoneycom
Coherus BioSciences $CHRS versus The Competition Head-To-Head Comparison https://t.co/qLK2JiwD6a
September 25th 2017, 11:09am
newswelldone @newswelldone
$ABBV $CHRS: UBS Downgrades AbbVie; Here’s What Changed Analysts’ View: https://t.co/so85ZXJAc2
September 25th 2017, 9:09am
dakotafinancial @dakotafinancial
Somewhat Positive News Coverage Somewhat Unlikely to Affect Coherus BioSciences $CHRS Share Price https://t.co/KvDQuioeLG
September 24th 2017, 12:09pm
SleekMoneycom @SleekMoneycom
Coherus BioSciences, Inc. $CHRS Given Outperform Rating at Cowen and Company https://t.co/YFs29HmDfD
September 24th 2017, 6:09am
MaisaCorp @MaisaCorp
$CHRS S-3 Files for offering of upto 6.56 million shares of common stock by the selling stockholder?
September 22nd 2017, 6:09pm
odibro @odibro
$CHRS S-3 shelf filed 6.5M shares
September 22nd 2017, 5:09pm
kshahi @kshahi
$CHRS https://t.co/TWzn1VpQbY
September 22nd 2017, 5:09pm
stocknewsdotcom @stocknewsdotcom
$CHRS Files for 6,556,116 share common stock offering by selling stockholders https://t.co/Kn39pVuAst
September 22nd 2017, 5:09pm
4thQuarterCap @4thQuarterCap
Trimmed $CHRS -10%
September 21st 2017, 7:09pm
midetimes @midetimes
Comparing Coherus BioSciences $CHRS & Its Competitors https://t.co/b46K0v9sju
September 20th 2017, 6:09pm
ZolmaxNews @ZolmaxNews
$CHRS - Comparing Coherus BioSciences #CHRS & Its Competitors https://t.co/FBWAuei5I8
September 20th 2017, 6:09pm
dailymailtimes @dailymailtimes
Comparing Coherus BioSciences $CHRS & Its Competitors https://t.co/NIHYGUqQ8A
September 20th 2017, 6:09pm
DPolitical @DPolitical
$CHRS - Comparing Coherus BioSciences #CHRS & Its Competitors https://t.co/5D2kYdLaxx
September 20th 2017, 6:09pm
TheMarketsDaily @TheMarketsDaily
Brokerages Set Coherus BioSciences, Inc. $CHRS Target Price at $34.78 https://t.co/EtoqlBtUUD
September 20th 2017, 6:09pm
SleekMoneycom @SleekMoneycom
Brokerages Set Coherus BioSciences, Inc. $CHRS Target Price at $34.78 https://t.co/c04BIrcgYi
September 20th 2017, 6:09pm
dailypoliticaln @dailypoliticaln
Comparing Coherus BioSciences $CHRS & Its Competitors https://t.co/q2OeaOlByB
September 20th 2017, 6:09pm
WKRBNews @WKRBNews
Comparing Coherus BioSciences $CHRS & Its Competitors https://t.co/IQZe3LSUL2
September 20th 2017, 6:09pm
SleekMoneycom @SleekMoneycom
Coherus BioSciences, Inc. $CHRS Cut to Hold at Zacks Investment Research https://t.co/R7NjbiLdc7
September 19th 2017, 8:09pm
dailymailtimes @dailymailtimes
Coherus BioSciences $CHRS – Research Analysts’ Weekly Ratings Updates https://t.co/h2aPDQQPEa
September 18th 2017, 5:09pm
WKRBNews @WKRBNews
Coherus BioSciences $CHRS – Research Analysts’ Weekly Ratings Updates https://t.co/FIsK9yu1JV
September 18th 2017, 5:09pm
midetimes @midetimes
Coherus BioSciences $CHRS – Research Analysts’ Weekly Ratings Updates https://t.co/WJL7hs0YBL
September 18th 2017, 5:09pm
intercooleronli @intercooleronli
Coherus BioSciences $CHRS – Research Analysts’ Weekly Ratings Updates https://t.co/GMJBh6LeVz
September 18th 2017, 5:09pm
dailypoliticaln @dailypoliticaln
Coherus BioSciences $CHRS – Research Analysts’ Weekly Ratings Updates https://t.co/Zo2WjJvAOv
September 18th 2017, 5:09pm
CFinancialNews @CFinancialNews
Coherus BioSciences $CHRS – Research Analysts’ Weekly Ratings Updates https://t.co/RC2GZZX4lh
September 18th 2017, 5:09pm
SleekMoneycom @SleekMoneycom
Head-To-Head Contrast: Coherus BioSciences $CHRS vs. The Competition https://t.co/qLK2JiwD6a
September 18th 2017, 11:09am
SPNewsAnalysis @SPNewsAnalysis
Head-To-Head Contrast: Coherus BioSciences $CHRS vs. The Competition https://t.co/Sa0DX5oOHj
September 18th 2017, 11:09am
emq_news @emq_news
Coherus BioSciences, Inc. $CHRS Stake Decreased by Pacad Investment Ltd. https://t.co/Ng30CMODL4
September 18th 2017, 6:09am
CFinancialNews @CFinancialNews
Coherus BioSciences, Inc. $CHRS Given Consensus Recommendation of “Buy” by Analysts https://t.co/1mCtMZEWfG
September 17th 2017, 1:09pm
intercooleronli @intercooleronli
Coherus BioSciences, Inc. $CHRS Given Consensus Recommendation of “Buy” by Analysts https://t.co/9IxfrJsJnr
September 17th 2017, 12:09pm
chaffeybreeze @chaffeybreeze
Coherus BioSciences, Inc. $CHRS Sees Large Volume Increase https://t.co/m1J1Phj5j1
September 17th 2017, 9:09am
IRAMarketReport @IRAMarketReport
Coherus BioSciences, Inc. $CHRS Sees Large Volume Increase https://t.co/jiW3qrdRrR
September 17th 2017, 9:09am
chaffeybreeze @chaffeybreeze
Critical Review: Zafgen $ZFGN and Coherus BioSciences $CHRS https://t.co/heYnBaLvVA
September 17th 2017, 5:09am
IRAMarketReport @IRAMarketReport
Critical Review: Zafgen $ZFGN and Coherus BioSciences $CHRS https://t.co/gpesEOaZgC
September 17th 2017, 5:09am
bnbdailynews @bnbdailynews
Coherus BioSciences’ $CHRS Buy Rating Reiterated at Maxim Group https://t.co/LvxWRKOqUa
September 16th 2017, 4:09pm
SleekMoneycom @SleekMoneycom
Coherus BioSciences, Inc. $CHRS Receives Outperform Rating from Cowen and Company https://t.co/YFs29HmDfD
September 16th 2017, 2:09pm
WatchlistN @WatchlistN
Coherus BioSciences, Inc. $CHRS Downgraded to Hold at Zacks Investment Research https://t.co/mpgICb8V58
September 16th 2017, 11:09am
TheMarketsDaily @TheMarketsDaily
Axa Buys 44,976 Shares of Coherus BioSciences, Inc. $CHRS https://t.co/RO9LSKcZig
September 16th 2017, 8:09am
TickerReport @TickerReport
Comparing Coherus BioSciences $CHRS and Its Rivals https://t.co/kPGSwmOW5z
September 16th 2017, 3:09am
TickerReport @TickerReport
Comparing Coherus BioSciences $CHRS and Its Rivals https://t.co/OMQJ1Bxy28
September 16th 2017, 3:09am
emq_news @emq_news
Comparing Coherus BioSciences $CHRS and Its Rivals https://t.co/KlLPNDw2IT
September 16th 2017, 3:09am
WeekHerald @WeekHerald
Coherus BioSciences, Inc. $CHRS Receives “Outperform” Rating from Cowen and Company https://t.co/YpoQS66p0i
September 15th 2017, 9:09pm
TickerReport @TickerReport
Coherus BioSciences, Inc. $CHRS Sees Large Volume Increase https://t.co/bwEKjIlh6s
September 15th 2017, 9:09pm
emq_news @emq_news
Coherus BioSciences, Inc. $CHRS Sees Large Volume Increase https://t.co/H2zOG2LmqW
September 15th 2017, 9:09pm
TickerReport @TickerReport
Coherus BioSciences, Inc. $CHRS Sees Large Volume Increase https://t.co/0V9t6lMu1v
September 15th 2017, 9:09pm
TheMarketsDaily @TheMarketsDaily
Coherus BioSciences, Inc. $CHRS Downgraded by Zacks Investment Research https://t.co/fUTP7kjl97
September 15th 2017, 12:09pm
fda_tracker @fda_tracker
$CHRS Phase 3 trial w/est Sep completion date NCT02486939: https://t.co/pGVkHSyWQj Trial Tracker: https://t.co/aR7q5oJwjn
September 15th 2017, 9:09am
SleekMoneycom @SleekMoneycom
Maxim Group Reiterates “Buy” Rating for Coherus BioSciences, Inc. $CHRS https://t.co/GERD4edUGX
September 15th 2017, 8:09am
intercooleronli @intercooleronli
Reviewing Coherus BioSciences $CHRS & Zafgen $ZFGN https://t.co/uwc2uA1kBq
September 14th 2017, 12:09pm
CFinancialNews @CFinancialNews
Reviewing Coherus BioSciences $CHRS & Zafgen $ZFGN https://t.co/Qg83LjKZRA
September 14th 2017, 12:09pm

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.